Importance of sample size in hospital point-of-care glucose measurements

Artikel in diesem Heft

1. Reviews
2. The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases
3. Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice
4. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories
5. Cardiovascular Diseases
6. APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels
7. Gender-modulated impact of apolipoprotein A5 gene (APOA5) −1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults
8. Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome
9. Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing
10. Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations
11. High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain
12. Genetics and Molecular Diagnostics
13. Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas
14. A novel MEN1 frameshift germline mutation in two Italian monozygotic twins
15. The silent hemoglobin α chain variant Hb Riccarton [α51(CE9)Gly→Ser] may affect HbA1c determination on the HLC-723 G7 analyzer
16. General Clinical Chemistry and Laboratory Medicine
17. Urinary fructose-1,6-bisphosphatase activity as a marker of the damage to the renal proximal tubules in children with idiopathic nephrotic syndrome
18. Antioxidant defense capacity in scleroderma patients
19. Correction of ventricular cerebrospinal fluid (CSF) samples for blood content does not increase sensitivity and specificity for the detection of CSF infection
20. Validation and Outcome Studies
21. Preanalytical quality control program – an overview of results (2001–2005 summary)
22. A laboratory-based risk score for medical intensive care patients
23. Analytical performance evaluation of the Cobas 6000 analyzer – special emphasis on trueness verification
24. Letters to the Editor
25. Quality planning and analytical quality requirements derived from biology
26. Importance of sample size in hospital point-of-care glucose measurements
27. Reliability of M protein quantification: comparison of two peak integration methods on Capillarys 2
28. What's in a name? Standardization of HbA1c
29. Serum paraoxonase 1 activities and homocysteinemia in hemodialysis patients